Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Rhythm: SGLT2 inhibitors & AFib | AI-powered ECG analysis | How AFib affects TMVR outcomes
Tuesday, April 20, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes

Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients.

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients.
READ MORE >

Heart rhythm specialists receive $3.67M to develop new atrial fibrillation treatment

The grant, from the National Heart, Lung, and Blood Institute, is for more than $462,000 at first. An additional $3.21 million can be earned if certain requirements are met. 

READ MORE >
According to calculations comparing catheter ablation with drug therapy, the additional quality-adjusted life-years that can result from the treatment justify its increased costs. 
Share on Twitter Share on Facebook Share on Linkedin

Heart rhythm specialists receive $3.67M to develop new atrial fibrillation treatment

Share on Twitter Share on Facebook Share on Linkedin
According to calculations comparing catheter ablation with drug therapy, the additional quality-adjusted life-years that can result from the treatment justify its increased costs. 
The grant, from the National Heart, Lung, and Blood Institute, is for more than $462,000 at first. An additional $3.21 million can be earned if certain requirements are met. 
READ MORE >

FDA details Class I recall of nearly 240,000 Medtronic ICDs, CRT-Ds

Medtronic first initiated the recall, which includes a total of 239,171 devices, in February.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA details Class I recall of nearly 240,000 Medtronic ICDs, CRT-Ds

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
Medtronic first initiated the recall, which includes a total of 239,171 devices, in February.
READ MORE >

New and improved: Hospital updates AFib ablation protocols, improves efficiency

“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New and improved: Hospital updates AFib ablation protocols, improves efficiency

Share on Twitter Share on Facebook Share on Linkedin
“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”
READ MORE >

FDA grants breakthrough device designation to AI-powered ECG analysis tool

Tempus, a Chicago-based healthcare technology company, collaborated with Geisinger on the solution.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA grants breakthrough device designation to AI-powered ECG analysis tool

Share on Twitter Share on Facebook Share on Linkedin
Tempus, a Chicago-based healthcare technology company, collaborated with Geisinger on the solution.
READ MORE >

COAPT update: How AFib affects TMVR outcomes

The new analysis, published in Circulation: Cardiovascular Interventions, focused on data from more than 600 patients who participated in the COAPT trial. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

COAPT update: How AFib affects TMVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
The new analysis, published in Circulation: Cardiovascular Interventions, focused on data from more than 600 patients who participated in the COAPT trial. 
READ MORE >

Wearable ECG devices detect AFib among older patients, reducing the risk of stroke

The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Wearable ECG devices detect AFib among older patients, reducing the risk of stroke

Share on Twitter Share on Facebook Share on Linkedin
The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older. 
READ MORE >

How heart rhythm issues affect 2-year TAVR, SAVR outcomes

The study’s authors explored data from more than 900 low-risk patients who participated in the PARTNER 3 trial.

READ MORE >
patient with heart doctor
Share on Twitter Share on Facebook Share on Linkedin

How heart rhythm issues affect 2-year TAVR, SAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
patient with heart doctor
The study’s authors explored data from more than 900 low-risk patients who participated in the PARTNER 3 trial.
READ MORE >

In Case You Missed It

AFib and atrial flutter in the United States: 5 key takeaways from a new analysis

The study, published in the American Journal of Cardiology, shines new light on a significant health issue. 

READ MORE >
doctors.jpg
Share on Twitter Share on Facebook Share on Linkedin

AFib and atrial flutter in the United States: 5 key takeaways from a new analysis

Share on Twitter Share on Facebook Share on Linkedin
doctors.jpg
The study, published in the American Journal of Cardiology, shines new light on a significant health issue. 
READ MORE >

AI predicts new-onset AFib using 12-lead ECGs

The team's deep neural network was trained on more than 1.6 million 12-lead ECGs. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI predicts new-onset AFib using 12-lead ECGs

Share on Twitter Share on Facebook Share on Linkedin
The team's deep neural network was trained on more than 1.6 million 12-lead ECGs. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme